On February 24, 2023 GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager, TriKE platform, reported that Dr. Jeffrey Miller, MD, GT Bipharma’s Consulting Chief Medical Officer and Chief Scientific Officer, will present a corporate overview at H.C. Wainwright’s Cell Therapy Virtual Conference taking place on February 28, 2023 (Press release, GT Biopharma, FEB 24, 2023, View Source [SID1234627679]). Company management will also be participating in 1×1 meetings during the event.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Cell Therapy Virtual Conference – February 28, 2023

Title: GT Biopharma (GTBP) Company Presentation
Date: Tuesday, February 28, 2023
Time: 9:00 – 9:20 am ET
Presenter: Dr. Jeffrey Miller, MD, Consulting CMO & CSO, GT Biopharma
Webcast Link: Register here
If you are interested in arranging a 1×1 meeting request with management, please contact your H.C. Wainwright representative.